Booster vaccinations against tick-borne encephalitis: 6 Years follow-up indicates long-term protection

Vaccine

Volumn 27, Issue 50, 2009, Pages 7027-7030

  Paulke Korinek, Maria ^a   Rendi Wagner, Pamela ^a,b   Kundi, Michael ^c   Laaber, Brigitte ^a   Wiedermann, Ursula ^a   Kollaritsch, Herwig ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b TEL AVIV UNIVERSITY   (Israel)

^c Medical University of Vienna   (Austria)

Author keywords

Booster intervals; Booster vaccination; Follow up study; Long term immunity; Long term protection; TBE; Tick borne encephalitis

Indexed keywords

NEUTRALIZING ANTIBODY; TICK BORNE ENCEPHALITIS VACCINE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; TICK BORNE ENCEPHALITIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; ENCEPHALITIS, TICK-BORNE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNIZATION, SECONDARY; MALE; MIDDLE AGED; NEUTRALIZATION TESTS; VIRAL VACCINES; YOUNG ADULT;

EID: 70350574691     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.09.068     Document Type: Article

References (23)

1. Thiel H-J, Collett MS, Gould EA, Heinz FX, Houghton M, Meyers G, et al. In: Index of viruses-flaviviridae. ICTVdB - The Universal Virus Database, Version 4. Büchen-Osmond C, Columbia University, New York; 2006. Available from: http://www.ncbi.nlm.nih.gov/ICTVdb/Ictv/fs_index.htm [last accessed 3.7.2009].
2. Süss J. Tick-borne encephalitis in Europe and beyond-the epidemiological situation as of 2007. Euro Surveill (2008) pii=18916
3. Rendi-Wagner P. Advances in vaccination against tick-borne encephalitis. Expert Rev Vaccines 7 5 (2008) 589-596
4. Kaiser R. Tick-borne encephalitis. Infect Dis Clin North Am 22 3 (2008) 561-575
5. Donchenko I., Kutsar K., and Vasilenko V. Tickborne encephalitis outbreak in Estonia linked to raw goat milk, May-June 2005. Euro Surveill 10 25 (2005) pii=2730
6. Kaiser R. The clinical and epidemiological profile of tick-borne encephalitis in southern Germany 1994-98: a prospective study of 656 patients. Brain 122 11 (1999) 2067-2078
7. Heinz F.X., Holzmann H., Essl A., and Kundi M. Field effectiveness of vaccination against tick-borne encephalitis. Vaccine 25 43 (2007) 7559-7567
8. Demicheli V., Debalini M., and Rivetti A. Vaccines for preventing tick-borne encephalitis. Cochrane Database Syst Rev (2009) CD000977
9. Kunz C. TBE vaccination and the Austrian experience. Vaccine 21 S1 (2003) S50-S55
10. Rendi-Wagner P. Risk and prevention of tick-borne encephalitis in travelers. J Travel Med 11 5 (2004) 307-312
11. Heinz F., and Kunz C. Tick-borne encephalitis and the impact of vaccination. Arch Virol Suppl 18 (2004) 201-205
12. Donoso M.O., Schädler R., and Niedrig M. A survey on cases of tick-borne encephalitis in European countries. Euro Surveill (2008) pii=18848
13. Süss J., Klaus C., Gerstengarbe F.W., and Werner P.C. What makes ticks tick? Climate change, ticks, and tick-borne diseases. J Travel Med 15 1 (2008) 39-45
14. Eidgenössische Kommission für Impffragen. Schweizerischer Impfplan 2008, Richtlinien und Empfehlungen (S VIII). In: Bundesamt für Gesundheit, Bern; 2008, p. 14.
15. Rendi-Wagner P., Kundi M., Zent O., Banzhoff A., Jaehnig P., Stemberger R., et al. Immunogenicity and safety of a booster vaccination against tick-borne encephalitis more than 3 years following the last immunisation. Vaccine 23 4 (2004) 427-434
16. Kreil T., Burger I., Bachmann M., Fraiss S., and Eibl M. Antibodies protect mice against challenge with tick-borne encephalitis virus (TBEV)-infected macrophages. Clin Exp Immunol 110 3 (1997) 358-361
17. Klockmann U., Bock H.L., Kwasny H., Praus M., Cihlová V., Tomková E., et al. Humoral immunity against tick-borne encephalitis virus following manifest disease and active immunization. Vaccine 9 1 (1991) 42-46
18. Rendi-Wagner P., Paulke-Korinek M., Kundi M., Wiedermann U., Laaber B., and Kollaritsch H. Seroprotection 4 years following booster vaccination against tick-borne encephalitis. Int J Med Microbiol 298 S1 (2008) 305-308
19. Rendi-Wagner P., Paulke-Korinek M., Kundi M., Wiedermann U., Laaber B., and Kollaritsch H. Antibody persistence following booster vaccination against tick-borne encephalitis: 3-year post-booster follow-up. Vaccine 25 27 (2007) 5097-5101
20. Oberster_Sanitätsrat. Impfplan 2008. Available from: http://www.bmgfj.gv.at/cms/site/attachments/1/4/0/CH0780/CMS1038913010412/impfplan_2009_final.pdf [last accessed 3.7.2009].
21. Hainz U., Jenewein B., Asch E., Pfeiffer K., Berger P., and Grubeck-Loebenstein B. Insufficient protection for healthy elderly adults by tetanus and TBE vaccines. Vaccine 23 25 (2005) 3232-3235
22. Siegrist C., and Aspinall R. B-cell responses to vaccination at the extremes of age. Nat Rev Immunol 9 3 (2009) 185-194
23. Rendi-Wagner P., Kundi M., Zent O., Dvorak G., Jaehnig P., Holzmann H., et al. Persistence of protective immunity following vaccination against tick-borne encephalitis-longer than expected?. Vaccine 22 21-22 (2004) 2743-2749